Viking Therapeutics (VKTX) Tops Q4 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance